
Sign up to save your podcasts
Or


On this week’s Tech Nation, Moira speaks with Dr. Emily Falk, Professor of Communications, Psychology, and Marketing at the University of Pennsylvania, about her new book, "What We Value... The Neuroscience of Choice and Change."
Then, Jeff Liter, Founder and CEO of Luminary Therapeutics, shares how new developments in cell therapy could make treatments for cancer and autoimmune diseases more affordable and accessible, without needing to be personalized for each patient.
By Tech Nation4.4
6060 ratings
On this week’s Tech Nation, Moira speaks with Dr. Emily Falk, Professor of Communications, Psychology, and Marketing at the University of Pennsylvania, about her new book, "What We Value... The Neuroscience of Choice and Change."
Then, Jeff Liter, Founder and CEO of Luminary Therapeutics, shares how new developments in cell therapy could make treatments for cancer and autoimmune diseases more affordable and accessible, without needing to be personalized for each patient.

22,021 Listeners

43,969 Listeners

32,152 Listeners

38,526 Listeners

6,740 Listeners

43,758 Listeners

27,200 Listeners

2,864 Listeners

9,182 Listeners

465 Listeners

724 Listeners

925 Listeners

6,352 Listeners

932 Listeners

32 Listeners